These findings will help scientists understand how to better diagnose and treat the disease.
risk
OMRF welcomes Positive Tomorrows for Halloween fun
Trick-or-treaters descend on OMRF for ninth consecutive year.
Oklahoma-based cancer test helps stop a killer
It took 14 years for Oklahoma City biotechnology company InterGenetics to research and develop its breast cancer risk assessment test, OncoVue. But less than a year after becoming commercially available, the test has already begun paying dividends to patients. A California oncologist reports that that the test, which has its origins in research conducted at […]
